Merge Labs
3 known investors
Find your way into Merge Labs
Merge Labs is a research lab developing brain-computer interfaces that connect with neurons using molecules instead of electrodes and non-invasive modalities like ultrasound, integrated with AI. It aims initially to help patients with injury or disease and later to broadly advance human capability.
Investors · 3
Funding
SEC filings, press & company announcements- $250Mseed roundJan 2026
Bain Capital, Fifty Years, Interface Fund, OpenAI
Source ↗ - $252MraisedJan 2026 · 2 sources
OpenAI (lead)
Source ↗
▶$10.1MraisedMay 2016 · 47 investors · Other TechnologyRule 506(b)
▶$10.1MraisedMay 2016 · 47 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew TrickettExecutive Officer, Director
- Franklin LyonsExecutive Officer, Director
- Lew MoormanDirector
- Offering amount
- $10.1M
- Amount sold
- $10.1M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Merge Labs: Rewriting the Human-AI Interfacetradeflockasia.com · Aug 2026Frequently asked questions
- What does Merge Labs do?
- Merge Labs is a research lab developing brain-computer interfaces that connect with neurons using molecules instead of electrodes and non-invasive modalities like ultrasound, integrated with AI. It aims initially to help patients with injury or disease and later to broadly advance human capability.
- Who are Merge Labs's investors?
- Merge Labs's investors include Anti, Big Brain Holdings, SciFi VC.